Pfizer abandons a NASH drug that, surprise surpris
Post# of 148160
https://www.fiercebiotech.com/biotech/nash-cu...3792801H0W
Quote:
It’s not the first NASH drug to be culled from Pfizer’s pipeline, either. The Big Pharma dropped the ketohexokinase inhibitor PF-06835919 after a mid-stage trial a year ago, and had previously halted PF-05221304 and a DGAT2 inhibitor for the liver condition.